Details for 2022769624
Up to date per 02.04.2026
Actions
Details for 2022769624
Granted/Registered
European Patent
20.09.2023 A
29.05.2024 B1
27.08.2021
US
202163237630 P
16.05.2022
US
202263364734 P
C07K 16/24 20060101AFI20231012BHEP
Owner
MedImmune Limited1 Francis Crick Avenue Cambridge Biomedical Campus Cambridge CB2 0AAGB
Representative
No representatives present
Inventor
SADIQ, Muhammad Waqas 151 85 SödertäljeSE
LOZANO, Eulalia Jimenez 28033 MadridES
Information about Fees